C. Martin Harris's Insider Trades & SAST Disclosures
C. Martin Harris's most recent trade in Colgate-Palmolive Co. was a trade of 2,272 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern C. Martin Harris.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Colgate-Palmolive Co. | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 2,272 | 2,272 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 1,514 | 22,801 (0%) | 0% | 0 | Common Stock | |
| Claritev Corp. - Ordinary ... | Harris Martin C. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 7,356 | 15,305 | - | 0 | Class A common stock | |
| Thermo Fisher Scientific Inc. | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 339 | 8,468 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 2,201 | 2,201 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 1,905 | 21,204 (0%) | 0% | 0 | Common Stock | |
| Claritev Corp. - Ordinary ... | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 172,413 | 318,003 | - | 0 | Class A common stock | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Sale of securities on an exchange or to another person at price $ 84.50 per share. | 31 Jan 2024 | 2,760 | 19,272 (0%) | 0% | 84.5 | 233,220 | Common Stock |
| Colgate-Palmolive Co. | Harris Martin C. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 2,760 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | C. Harris Martin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.04 per share. | 31 Jan 2024 | 2,760 | 22,032 (0%) | 0% | 62.0 | 171,230 | Common Stock |
| Thermo Fisher Scientific Inc. | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 392 | 8,129 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 2,884 | 2,884 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 2,220 | 19,244 (0%) | 0% | 0 | Common Stock | |
| Claritev Corp. - Ordinary ... | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2023 | 106,382 | 145,590 | - | 0 | Class A common stock | |
| Agiliti Inc | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 11,800 | 19,150 | - | 0 | Common Stock, $0.0001 par value | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Sale of securities on an exchange or to another person at price $ 74.25 per share. | 21 Feb 2023 | 5,703 | 17,010 (0%) | 0% | 74.2 | 423,447 | Common Stock |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 5,703 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.65 per share. | 21 Feb 2023 | 5,703 | 22,713 (0%) | 0% | 71.7 | 408,620 | Common Stock |
| Agiliti Inc | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 7,350 | 7,350 | - | 0 | Common Stock, $0.0001 par value | |
| Thermo Fisher Scientific Inc. | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 369 | 7,737 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 3,122 | 3,122 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 2,317 | 16,967 (0%) | 0% | 0 | Common Stock | |
| Claritev Corp. - Ordinary ... | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 22,271 | 39,208 | - | 0 | Class A common stock | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Sale of securities on an exchange or to another person at price $ 82.76 per share. | 02 Feb 2022 | 4,491 | 14,650 (0%) | 0% | 82.8 | 371,675 | Common Stock |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.76 per share. | 02 Feb 2022 | 4,491 | 19,141 (0%) | 0% | 71.8 | 322,274 | Common Stock |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 4,491 | 0 | - | - | Stock Option (Right to Buy) | |
| Thermo Fisher Scientific Inc. | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 438 | 7,368 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 3,611 | 3,611 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 1,620 | 14,650 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 3,569 | 2,760 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive Co. | C. Martin Harris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.04 per share. | 04 Feb 2021 | 3,569 | 13,030 (0%) | 0% | 62.0 | 221,421 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges